ATE500319T1 - Verfahren zur verwendung von aus fettgewebe stammenden zellen bei der behandlung von herz- kreislauf-leiden - Google Patents
Verfahren zur verwendung von aus fettgewebe stammenden zellen bei der behandlung von herz- kreislauf-leidenInfo
- Publication number
- ATE500319T1 ATE500319T1 AT05754073T AT05754073T ATE500319T1 AT E500319 T1 ATE500319 T1 AT E500319T1 AT 05754073 T AT05754073 T AT 05754073T AT 05754073 T AT05754073 T AT 05754073T AT E500319 T1 ATE500319 T1 AT E500319T1
- Authority
- AT
- Austria
- Prior art keywords
- cells
- treatment
- cells derived
- cardiovascular diseases
- fat tissue
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1891—Angiogenesic factors; Angiogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0653—Adipocytes; Adipose tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2005/018605 WO2006127007A2 (en) | 2005-05-25 | 2005-05-25 | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE500319T1 true ATE500319T1 (de) | 2011-03-15 |
Family
ID=37452485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05754073T ATE500319T1 (de) | 2005-05-25 | 2005-05-25 | Verfahren zur verwendung von aus fettgewebe stammenden zellen bei der behandlung von herz- kreislauf-leiden |
Country Status (12)
Country | Link |
---|---|
EP (2) | EP1885382B1 (de) |
JP (1) | JP5210155B2 (de) |
KR (2) | KR101400544B1 (de) |
CN (1) | CN101443023A (de) |
AT (1) | ATE500319T1 (de) |
AU (1) | AU2005332046B2 (de) |
CA (1) | CA2609361C (de) |
DE (1) | DE602005026724D1 (de) |
DK (1) | DK1885382T3 (de) |
ES (1) | ES2364689T3 (de) |
PL (1) | PL1885382T3 (de) |
WO (1) | WO2006127007A2 (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9597395B2 (en) | 2001-12-07 | 2017-03-21 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
WO2003053346A2 (en) | 2001-12-07 | 2003-07-03 | Macropore Biosurgery, Inc. | Systems and methods for treating patients with processed lipoaspirate cells |
US20050048035A1 (en) | 2001-12-07 | 2005-03-03 | Fraser John K. | Methods of using regenerative cells in the treatment of stroke and related diseases and disorders |
US20050095228A1 (en) | 2001-12-07 | 2005-05-05 | Fraser John K. | Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders |
US7771716B2 (en) | 2001-12-07 | 2010-08-10 | Cytori Therapeutics, Inc. | Methods of using regenerative cells in the treatment of musculoskeletal disorders |
US8622997B2 (en) | 2005-03-23 | 2014-01-07 | Ronald D. Shippert | Tissue transfer method and apparatus |
US9581942B1 (en) | 2005-03-23 | 2017-02-28 | Shippert Enterprises, Llc | Tissue transfer method and apparatus |
US7789872B2 (en) | 2005-03-23 | 2010-09-07 | Shippert Ronald D | Tissue transplantation method and apparatus |
US8062286B2 (en) | 2005-03-23 | 2011-11-22 | Shippert Ronald D | Tissue transplantation method and apparatus |
US7780649B2 (en) | 2005-03-23 | 2010-08-24 | Shippert Ronald D | Tissue transplantation method and apparatus |
US7794449B2 (en) | 2005-03-23 | 2010-09-14 | Shippert Ronald D | Tissue transplantation method and apparatus |
ES2325715B1 (es) | 2007-08-03 | 2010-06-17 | Genetrix, S.L. | Poblacion de celulas madre adultas derivadas de tejido adiposo cardiaco y su uso en regeneracion cardiaca. |
WO2010021993A1 (en) | 2008-08-19 | 2010-02-25 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease |
KR101679671B1 (ko) * | 2009-10-27 | 2016-11-28 | 도병록 | 재생성 세포 추출 시스템 |
US8887770B1 (en) | 2011-03-17 | 2014-11-18 | Ronald D. Shippert | Vessel fill control method and apparatus |
CN102151153A (zh) * | 2011-03-25 | 2011-08-17 | 吴成翰 | 外科手术过程中组织碎片的回收装置 |
JP5628131B2 (ja) * | 2011-10-19 | 2014-11-19 | サイトリ セラピューティクス インコーポレイテッド | 心血管状態の治療において脂肪組織由来細胞を使用する方法 |
DE102013209718B4 (de) * | 2012-06-22 | 2015-09-10 | Human Med Ag | Vorrichtung zum Separieren von adulten Stammzellen |
US9259435B2 (en) | 2012-08-31 | 2016-02-16 | W. L. Gore & Associates, Inc. | Reactive oxidative species generating materials and methods of use |
US9468709B2 (en) | 2012-11-12 | 2016-10-18 | Shippert Enterprises, Llc | Syringe fill method and apparatus |
US9580678B2 (en) | 2013-06-21 | 2017-02-28 | The Regents Of The University Of California | Microfluidic tumor tissue dissociation device |
WO2015131087A1 (en) * | 2014-02-28 | 2015-09-03 | Cytovera Inc. | A system for tissu manipulation |
US10772997B2 (en) | 2014-05-15 | 2020-09-15 | Ronald D. Shippert | Tissue parcelization method and apparatus |
DE102015109148B3 (de) * | 2015-06-10 | 2016-05-04 | Human Med Ag | Vorrichtung zum Separieren von regenerativen und adulten Stammzellen |
CN106318905A (zh) * | 2015-07-10 | 2017-01-11 | 中国科学院上海生命科学研究院 | 血栓烷素a2受体作为脂肪干细胞治疗缺血性疾病的靶标 |
CN108472319B (zh) * | 2016-01-19 | 2021-12-28 | 国立大学法人大阪大学 | 用于治疗心脏病的移植材料 |
US10722540B1 (en) | 2016-02-01 | 2020-07-28 | The Regents Of The University Of California | Microfluidic device and method for shear stress-induced transformation of cells |
IL263422B (en) | 2016-06-08 | 2022-09-01 | Univ California | Method and device for processing tissues and cells |
JP6256786B1 (ja) * | 2017-04-12 | 2018-01-10 | 学校法人福岡大学 | 不妊症の処置に用いられる医薬組成物およびその製造方法 |
CN107988151A (zh) * | 2017-12-06 | 2018-05-04 | 北京大学第三医院 | 一种体外诱导带血管蒂的脂肪组织成肌方法 |
US20230063104A1 (en) * | 2020-02-04 | 2023-03-02 | Hierabio Inc | Composition for intrapericardial injection comprising stem cells and use thereof |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US482820A (en) | 1892-09-20 | Ernest p | ||
US6238908B1 (en) | 1995-06-07 | 2001-05-29 | Aastrom Biosciences, Inc. | Apparatus and method for maintaining and growth biological cells |
FR2742662B1 (fr) | 1995-12-21 | 1998-01-23 | Centre Nat Rech Scient | Anticorps anti-idiotypiques du facteur de croissance endotheliale vasculaire et leur utilisation comme medicaments |
US6280473B1 (en) | 1996-08-19 | 2001-08-28 | Macropore, Inc. | Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration |
US5919234A (en) | 1996-08-19 | 1999-07-06 | Macropore, Inc. | Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration |
DK1007631T4 (da) * | 1997-07-14 | 2009-04-27 | Osiris Therapeutics Inc | Hjertemuskelregeneration ved anvendelse af mesenkymale stamceller |
US6269716B1 (en) | 1998-11-18 | 2001-08-07 | Macropore, Inc. | High-torque resorbable screws |
ATE286692T1 (de) | 1998-04-07 | 2005-01-15 | Macropore Inc | Membran mit gewellter oberfläche zur führung des gewebes |
US6001642A (en) | 1998-06-29 | 1999-12-14 | Wyle Laboratories, Inc. Life Sciences | Bioreactor and cell culturing processes using the bioreactor |
AU3081801A (en) | 1999-11-15 | 2001-05-30 | Chemclean Corporation | Bio-burden visualization system |
PT1852087E (pt) | 2000-03-10 | 2011-07-25 | Mast Biosurgery Ag | Micromembrana reabsorvível para atenuação de tecido cicatricial |
US7094874B2 (en) | 2000-05-26 | 2006-08-22 | Bristol-Myers Squibb Co. | Soluble CTLA4 mutant molecules |
AU2002211449A1 (en) | 2000-10-04 | 2002-04-15 | James Peter Amis | Non-scatterable, radio-opaque marker for medical imaging applications |
FR2819265B1 (fr) * | 2001-01-10 | 2004-01-02 | Centre Nat Rech Scient | Cellules du tissu adipeux extramedullaire et leurs applications dans la reconstitution des lignees hematopoietiques |
JP2004532202A (ja) * | 2001-03-15 | 2004-10-21 | シアオ,ヨング−フー | 生存哺乳動物における臨床的に認められた形態の心臓の病状を治療的に処置する方法 |
US20050008626A1 (en) * | 2001-12-07 | 2005-01-13 | Fraser John K. | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
WO2003053346A2 (en) * | 2001-12-07 | 2003-07-03 | Macropore Biosurgery, Inc. | Systems and methods for treating patients with processed lipoaspirate cells |
JP2004099471A (ja) * | 2002-09-05 | 2004-04-02 | Cardio Corp | 心筋梗塞および心不全の治療薬 |
RU2372924C2 (ru) * | 2003-02-20 | 2009-11-20 | Ситори Терапьютикс,Инк | Применение композиции, состоящей из концентрированной клеточной популяции, представляющей собой стволовые клетки и недифференцированные клетки-предшественники |
CA2530630A1 (en) * | 2003-06-25 | 2005-02-10 | Macropore Biosurgery Inc. | Systems and methods for separating and concentrating regenerative cells from tissue |
ES2633604T3 (es) * | 2003-09-17 | 2017-09-22 | Cytori Therapeutics, Inc. | Métodos para usar células regenerativas derivadas de adiposo en el tratamiento de una enfermedad vascular periférica |
DE602004024125D1 (de) * | 2003-12-25 | 2009-12-24 | Kanazawa University Technology | Induktion einer myokardzelle unter verwendung einer säuger-knochenmarkzelle oder aus nabelschnurblut stammenden zelle und fettgewebe |
-
2005
- 2005-05-25 CN CNA2005800502651A patent/CN101443023A/zh active Pending
- 2005-05-25 EP EP05754073A patent/EP1885382B1/de not_active Not-in-force
- 2005-05-25 KR KR1020137005581A patent/KR101400544B1/ko active IP Right Grant
- 2005-05-25 DK DK05754073.4T patent/DK1885382T3/da active
- 2005-05-25 DE DE602005026724T patent/DE602005026724D1/de active Active
- 2005-05-25 KR KR1020077030170A patent/KR101278437B1/ko active IP Right Grant
- 2005-05-25 JP JP2008513441A patent/JP5210155B2/ja active Active
- 2005-05-25 AU AU2005332046A patent/AU2005332046B2/en not_active Ceased
- 2005-05-25 CA CA2609361A patent/CA2609361C/en not_active Expired - Fee Related
- 2005-05-25 ES ES05754073T patent/ES2364689T3/es active Active
- 2005-05-25 PL PL05754073T patent/PL1885382T3/pl unknown
- 2005-05-25 EP EP11152868.3A patent/EP2465923B1/de not_active Not-in-force
- 2005-05-25 AT AT05754073T patent/ATE500319T1/de not_active IP Right Cessation
- 2005-05-25 WO PCT/US2005/018605 patent/WO2006127007A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
PL1885382T3 (pl) | 2011-09-30 |
WO2006127007A3 (en) | 2009-04-16 |
ES2364689T3 (es) | 2011-09-12 |
KR101400544B1 (ko) | 2014-05-27 |
CN101443023A (zh) | 2009-05-27 |
KR20130038412A (ko) | 2013-04-17 |
EP1885382A4 (de) | 2009-09-09 |
CA2609361A1 (en) | 2006-11-30 |
CA2609361C (en) | 2017-11-14 |
KR101278437B1 (ko) | 2013-06-25 |
EP2465923B1 (de) | 2018-04-11 |
KR20080017389A (ko) | 2008-02-26 |
AU2005332046B2 (en) | 2013-05-16 |
WO2006127007A2 (en) | 2006-11-30 |
EP2465923A3 (de) | 2012-06-27 |
DE602005026724D1 (de) | 2011-04-14 |
AU2005332046A1 (en) | 2006-11-30 |
EP1885382A2 (de) | 2008-02-13 |
EP2465923A2 (de) | 2012-06-20 |
JP2008545687A (ja) | 2008-12-18 |
EP1885382B1 (de) | 2011-03-02 |
DK1885382T3 (da) | 2011-06-20 |
JP5210155B2 (ja) | 2013-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE500319T1 (de) | Verfahren zur verwendung von aus fettgewebe stammenden zellen bei der behandlung von herz- kreislauf-leiden | |
ATE524070T1 (de) | Verfahren zur verwendung von aus fettgewebe stammenden zellen bei der behandlung von herz- kreislauf-leiden | |
WO2005034843A3 (en) | Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders | |
WO2006014159A3 (en) | Methods of using regenerative cells in the treatment of musculoskeletal disorders | |
AU2009100401A4 (en) | Method of extracting and activating adipose-derived stem cells | |
DE602004031782D1 (de) | Verfahren zur verwendung regenerativer zellen zur förderung der wundheilung | |
DE602006007093D1 (de) | Kombinationstherapie zur Behandlung von Diabetes und dadurch bedingten Leiden sowie zur Behandlung von mittels Erhöhung des GLP-1-Spiegels im Blut verbesserten Leiden | |
ATE481978T1 (de) | Zusammensetzungen und verfahren zur behandlung von herzkrankheiten | |
ATE355852T1 (de) | Verwendung von botulinum toxin zur behandlung von herz- und kreislaufskrankheiten | |
DE602005026866D1 (de) | Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen | |
MY197091A (en) | Compositions for treating acid-base disorders | |
MX2021013880A (es) | Polimeros enlazados al proton para administracion oral. | |
MX2019014711A (es) | Polimeros de union a protones para administracion oral. | |
WO2006022612A3 (en) | Methods of using regenerative cells in the treatment of stroke and related diseases and disorders | |
ATE511401T1 (de) | Kombinierte gentherapie zur behandlung makroskopischer glioma | |
EA201591522A1 (ru) | Лечение реакции трансплантат против хозяина у подвергаемых трансплантации пациентов | |
ATE478942T1 (de) | Verfahren zur verwendung regenerativer zellen bei der behandlung von nierenkrankheiten und störungen | |
TW201614066A (en) | Composition for treatment of joint disease and method thereof | |
ATE510530T1 (de) | Verfahren zur verhinderung und/oder behandlung von altersflecken | |
ATE526984T1 (de) | Knochen-morphogenetische proteine zur verwendung zur behandlung und prävention von neuroblastomen | |
MX2011011114A (es) | Materiales y metodos para utilizar celulas madre de tejido adiposo para tratar una lesion y enfermedad pulmonar. | |
Tawonsawatruk | Development of a clinically relevant strategy to promote fracture healing in an atrophic non-union model using mesenchymal stem cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |